Reports

The Future of Energy: Battery Metals and the Companies Leading the Charge

I’ve spent countless hours researching the future of energy, and I can tell you with utmost certainty that we’re on the brink of a revolution. The key to this revolution? Battery metals.

The Linchpin of the Energy Revolution: Why Battery Metals Matter

The Shift to Renewable Energy

As the world grapples with the realities of climate change, there’s been a seismic shift towards renewable energy sources like solar, wind, and hydro. Unlike fossil fuels, which provide consistent power, renewable sources are intermittent. The sun doesn’t always shine, and the wind doesn’t always blow. This is where batteries come into play. They store excess energy when it’s available and release it when it’s needed, ensuring a consistent power supply.

The Rise of Electric Vehicles (EVs)

The transportation sector is undergoing a transformation. The days of gasoline-powered vehicles are numbered, with EVs poised to take over. These vehicles rely heavily on batteries, and by extension, battery metals. As EV adoption rates soar, the demand for these metals will skyrocket.

Grid Energy Storage

As our energy grids evolve, there’s a growing need for large-scale energy storage solutions. Batteries are becoming integral to these grids, helping stabilize them and ensuring consistent energy supply. This is especially crucial as we transition to a more decentralized energy system with multiple renewable sources feeding into the grid.

The Dependence of Other Energy Forms on Batteries

While batteries are synonymous with renewable energy, they’re also becoming crucial for other forms of energy. Even nuclear and fossil fuel plants are beginning to see the benefits of integrating battery storage to handle peak demands and stabilize their output.

The Percentage of Energy Flowing Through Batteries

It’s challenging to pinpoint an exact percentage of energy that will flow through batteries in the future. However, projections suggest that by 2040, batteries could facilitate up to 25% of the world’s energy storage needs, with that number potentially rising as technology advances and adoption rates increase.

The Metals Powering Our Future

Before we dive into the companies that are leading the charge, let’s first understand the metals that are at the heart of this revolution:

  1. Lithium: Often referred to as “white petroleum,” lithium is the backbone of the battery industry. It’s light, highly reactive, and can store a significant amount of energy. The demand for lithium has skyrocketed with the rise of electric vehicles (EVs) and renewable energy storage solutions.
  2. Cobalt: This is a crucial component in many lithium-ion batteries. It helps increase the lifespan of batteries and is vital for high-energy applications like EVs. However, its sourcing has been controversial due to unethical mining practices in certain regions.
  3. Nickel: As battery technologies evolve, nickel is becoming increasingly important. High-nickel batteries offer greater energy density and are becoming the standard for EVs.
  4. Graphite: While not a metal, graphite is essential for lithium-ion batteries. It’s used as the anode in these batteries and plays a crucial role in determining the battery’s performance and lifespan.
  5. Vanadium: This metal is gaining traction for its use in vanadium redox flow batteries. These batteries are particularly suited for large-scale energy storage, making them perfect for grid applications.

Now, with a basic understanding of the metals that are shaping our future, let’s delve into the companies that are at the forefront of this industry.

The Top 3 Battery Metals Stocks to Buy

1. Albemarle Corporation (ALB)

Albemarle is one of the world’s largest lithium producers. With operations spanning from Australia to South America, they have a diversified portfolio of assets. Their commitment to sustainable and ethical mining practices sets them apart in an industry rife with controversy. As the demand for lithium continues to grow, Albemarle is poised to reap the benefits.

2. Glencore (GLEN)

Glencore is a giant in the mining industry, and when it comes to cobalt, they’re leading the pack. With a keen eye on the future, they’ve been ramping up their cobalt production in anticipation of the surge in demand from the EV industry. Their operations in the Democratic Republic of Congo, despite the challenges, have positioned them as a key player in the battery metals space.

3. Norilsk Nickel (NILSY)

As the name suggests, Norilsk Nickel is a titan in the nickel industry. But they’re not just about nickel; they’re also one of the largest producers of palladium and platinum. Their operations in Russia give them access to some of the richest nickel deposits in the world. As the shift towards high-nickel batteries continues, Norilsk stands to benefit immensely.

In Conclusion

The energy revolution is upon us, and battery metals are at its core. As the world moves towards a more sustainable future, the demand for these metals is set to explode. Companies like Albemarle, Glencore, and Norilsk Nickel are perfectly positioned to capitalize on this trend.

But remember, while the future looks bright, the mining industry is fraught with challenges. It’s essential to do your due diligence before making any investment decisions.

Where to invest $500 Right Now?

Before you consider buying any of the stocks in our reports, you’ll want to see this.

Investing legend, Marc Chaikin just revealed his #1 stock for 2024

And it’s not in any of our reports.

During his career of nearly 50 years, Marc Chaikin was one of the quantitative minds behind some of the most famous investors in history: Paul Tudor Jones, George Soros, Steve Cohen, and Michael Steinhardt.

Even the Nasdaq hired him to create three new indices.

And now he’s going live with his #1 pick for 2024.

You can learn all about it on Mr. Chaikin’s Website, here.

Wondering what stock he’s investing in?

Click here to watch his presentation, and learn for yourself

But you have to act now, because a catalyst coming in a few weeks is set to take this company mainstream… And by then, it could be too late.

Click here to reveal the name and ticker of Marc Chaikin’s no. 1 pick for 2024


These Overlooked Stocks Are Down But Far From Out 

As we look forward to the winter season (and Q3 earnings reports), the hottest products that the market offers right now are still brought to us through AI-related advancements. The rally never quite ended, as it turns out. 

As investors, it’s typically more prudent (and more popular) to identify stocks with high trading volume and price movement rather than focus on stocks that aren’t performing in obvious ways. 

Some stocks, however, can surprise us. For example, a stock may show inconsistency under normal conditions only to excel when chaos ensues. We should always, within reason, keep an open mind. 

Under-the-radar stocks are alluring for their upside potential, and while some are overlooked for a good reason, there are always opportunities that will thrive with some patience… 

General Motors Co (GM) 

Firstly, while it may only be me, consider giving General Motors (GM) and its stock some thought. While it may not immediately come to mind as a profitable investment, compelling reasons exist to explore GM. There’s only been a slight decline in the stock’s value since the year began, and GM still holds substantial potential to add wealth to one’s portfolio. GM, smartly, has been embracing EV (electric vehicle) technology for its iconic car brands, including even the once-prestigious Corvette. In contrast to a certain unnamed competitor known for uninspiring and occasionally eccentric designs, GM offers excitement and innovation. GM shows profitability and pays an honest dividend in relation to its bargain pricing. 

Down year-to-date by 3.21%, GM is trading around the bottom of its existing range and shows a lot of upside potential as a result. With a 1.63x PEG (price/earnings to growth) ratio, GM has a P/S (price to sales) ratio of 0.27x and a P/B (price to book) ratio of 0.63x. For Q2 2023, GM beat analysts’ projections on EPS and revenue by 3.98% and 5.61%, respectively, and also reported year-over-year growth in revenue (+25.13%), net income (+51.65%), EPS (+60.53%), and net profit margin (+21.14%). For the current fiscal quarter, GM is expected to post $41.8 billion in sales at $1.64 per share, with a 3-5 year EPS growth rate of 15.4%. GM has a 1.11% annual dividend yield and a quarterly payout of 9 cents ($0.36/year) per share. With a 10-day average volume of 9.51 million shares, GM has a median price target of $44.50, with a high of $95 and a low of $33; this suggests a potential price increase of more than 191% from where it is now. 

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”GM” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Alibaba Group Holding Ltd (BABA) 

One that you could call a “sleeper stock” for sure would be Alibaba Group Holdings (BABA). Currently flying under the radar and doing so cautiously, BABA is worth considering before making investment decisions. With uncertainties surrounding the Chinese economy and consumer base, BABA has provided modest returns year-over-year and year-to-date. However, this e-commerce and tech giant could benefit from any positive catalyst to help it take off again. Overall analyst sentiment suggests potential for future success, but it’s important to remain careful with BABA due to China’s sluggish economic growth. 

BABA is slightly up year-to-date by 2.14%, is trading around the middle of its existing high-low range, has a beta score of 0.70, a PEG ratio of 1.01x, and a healthy D/E (debt to equity) measure of 16.17%. For its Q2 earnings report, BABA exceeded analysts’ expectations on EPS and revenue by margins of 20.10% and

4.11%, respectively; it is projected to hold a 3-5 year EPS growth rate of 6.6%. BABA also posted year-over-year growth in critical areas like revenue (+13.91%), net income (+51.12%), EPS (+56.84%), and net profit margin (+32.67%). With a 10-day average volume of 13.06 million shares, BABA has a median price target of $139.83, with a high of $186.30 and a low of $78.32; this suggests the potential for a price jump of more than 107% from its current trading position. 

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”BABA” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Qualcomm Inc (QCOM) 

Qualcomm Inc. (QCOM) exists in an area of the marketplace that is extremely competitive right now, and it’s important to keep that in mind. While the tech innovator may not hold up to certain scrutiny, QCOM is still a compelling investment option. Despite facing challenges in the chip manufacturing industry due to consumer slowdowns in smartphones and PCs, QCOM is still very much a specialist in wireless 

semiconductors. While it’s shown modest gains year-to-date compared to the Nasdaq’s 35% increase, QCOM is worth a closer look. Notably, Wall Street analysts overwhelmingly rate QCOM as a “Strong Buy.” Let’s not forget that the standards it faces aren’t exactly easy for any company to live up to. 

QCOM is down year-to-date by 3.23%, and is trading near the very bottom of its existing 52-week range, which leaves space for its value to grow. With a 1.10x PEG ratio, QCOM, for Q2 2023, reported EPS of $1.87 per share vs. $1.81 per share as expected, making for a 3.35% defeat over analysts’ projections. For the present fiscal quarter, QCOM is expected to post $8.8 billion at $1.94 per share, with a 3-5 year EPS growth rate of 33.4%. Boasting a TTM (trailing twelve-month) free cash flow of $7.15 billion, QCOM has a 3.01% annual dividend yield and a quarterly payout of 80 cents ($3.20/year) per share. With a 10-day average volume of 6.8 million shares, QCOM has a median price target of $140, with a high of $167.70 and a low of $95; this indicates potential for a price jump of over 57% from where it trades currently. 

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”QCOM” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Steer Clear of These Sluggish Pot Stocks 

We can safely say that the fascination around marijuana legalization has diminished recently, at least as an investment strategy. For instance, the enthusiasm we saw leading up to legalization in certain parts of the U.S. hasn’t quite held up. However, anticipation continues to trend across the entire sector

Experts predict that yearly growth rates in the cannabis industry will continue to grow between now and 2030. But this is based on the anticipation I mentioned above—for federal legalization, to be specific. Sadly, anticipation alone isn’t quite enough to validate investing in the cannabis market. Not right now. 

The stocks I’ll cover today are each cheap and will likely grow in the future, but the industry likely won’t be profitable to public shareholders until it is legalized on a federal level. We can’t say when that will be, so why not just wait and observe? Cannabis will still be here in a couple of years, I’m sure. 

Although many agree cannabis will one day be legal in all 50 states, there are more pressing issues right now, not to mention a lot more profitable portfolio choices we could make… 

Cronos Group (CRON) 

Let’s start with the only one on this list currently trading on the New York Stock Exchange (while the other two are “over-the-counter”). Cronos Group (CRON) has demonstrated some positive changes, but it’s important to be weary; its stock is down year-to-date by 28.74% and hasn’t shown that much movement. Although net losses have reduced overall, earnings reports for both Q1 and Q2 of 2023 revealed revenue figures for CRON that came in well below analysts’ estimates. Most recently, CRON reported $25.45 million in sales vs. $29.83 million as expected, losing to projections by -14.68% and also showing a year-over-year revenue growth decline of -11.98%. CRON is set to report Q3 earnings on November 14th. 

CRON’s outlook is predicting positive cash flow to start coming within the next couple of years, but until then, the stock retains a negative SMA (simple moving average), a negative ROE (return on equity), and TTM (trailing twelve-month) asset declines and momentum declines. Despite CRON’s substantial liquidity reserves, its market valuation might not fully account for all the potential long-term challenges and fluctuations in the market, which could greatly impact the stock’s performance. Currently trading near the very bottom of its existing 52-week range, CRON has an average price target of $2.51, with a high of $3.77 and a low of $1.57. This leaves what will resonate through this list: potential for price upside but no momentum to drive and fulfill that potential, which otherwise could make it a promising growth stock. 

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”CRON” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Cresco Labs Inc (CRLBF) 

Cresco Labs (CRLBF) has garnered attention in the cannabis arena with its trading price under $2 and vertically integrated operations covering 10 states and 68 dispensaries. However, CRLBF’s recent stock performance shows a contraction in sales from $214 million to $194 million in Q1 2023, casting doubt on its growth trajectory. In Q2 2023, CRLBF reported EPS of -$0.04 per share, which met analysts’ expectations and beat slightly on revenue. However, revenue fell year-over-year by -9.06%, while net profit margin growth declined by -4.67%. CRLBF is set to report earnings again (for Q3) on November 9th.

Regarding current stock performance, CRLBF is down year-to-date by 39.44%, and although it’s trading under $2, it’s been a little too long for comfort. CRLBF has a negative 20/200 day SMA, a negative ROE, and negative TTM growth in both its momentum and asset management. While CRLBF’s operational gains have improved, overall net losses persist, and it hopes to use its vertical integration strategy to curb said losses. Trading near the bottom of its 52-week range, CRLBF has a median price target of $3.91, with a high of $12.19 and a low of $1.49. The problem for CRLBF is that it’s too uncertain whether or not it can ensure a clear path to profitability in an industry recently defined by its significant financial woes.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”CRLBF” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Green Thumb Industries Inc (GTBIF) 

While Green Thumb Industries (GTBIF) is often lauded for its profitability within the cannabis sector, a closer examination reveals potential shortcomings. Despite GTBIF’s consistent gross profits and net gains, its drop from $29.7 million to $9.4 million in Q1’s net income already suggested cost pressures that could hurt profits. For Q2 2023, year-over-year growth showed contractions in all the major categories: revenue (-0.76%), net income (-45.17%), EPS (-50%), and net profit margin (-44.75%). GTBIF is projected to post $266 million in sales at $0.06 per share for Q3 and is scheduled to report again on November 8th. 

GTBIF is currently down by 22.22% year-to-date, has a negative 20/200 day SMA, a negative ROE, and a declining TTM momentum growth measure. GTBIF’s stock has been trading attractively and is certainly contending strongly against its peers in the industry. However, the inherent unpredictability of the cannabis market is what introduces risks. Despite being the largest on this list when it comes to its market valuation, GTBIF has the lowest 10-day average volume, at roughly 235 thousand shares. As you may have guessed, GTBIF is, like its peers, trading near the bottom of its existing 52-week range; currently, GTBIF’s average price target is $15.87, with a high of $23.79 and a low of $10. This indicates the typical potential for upside minus the impressionable metrics you’d typically see in a compelling growth stock. 

There’s no harm at all in keeping an eye on GTBIF, or any other stock in the cannabis industry for that matter, on this last and even off. What’s most important about investing in this industry is that you keep an eye on both the sector’s performance and that of any given individual stock. The lasting and popular marijuana businesses are likely to make waves in the future, but that isn’t likely to happen until it’s federally legal, and frankly, marijuana legalization is far beyond our biggest issue right now. Patience. 

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”GTBIF” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

These Reliable Dividend Stocks Offer Excellent Passive Income

It should be no secret to any of our readers by now that we love dividend stocks. There is a clear and overarching reason why: Regardless of any given dividend stock’s trading price, the best among them will offer peace of mind to an investor’s portfolio through quarterly payouts

Some are considered more reliable than others, and the best way to make that distinction is to be sure the right stock metrics are there to sustain the payouts. Examples of such metrics include a positive free cash flow, a high payout ratio, and a beta score below 1 (which indicates safety from market volatility). 

The greatest income-generating stocks should be well-established and have healthy balance sheets to ensure their robust dividends stay in place. Potential price appreciation helps, too. 

I’ve landed on a few dividend payers that show incredible consistency and resiliency. Wall Street’s brightest experts and analysts concede that these should be bought and held… 

Restaurant Brands International Inc (QSR) 

First up on the list is Restaurant Brands International (QSR), the parent company of popular chains like Tim Horton’s, Burger King, Popeye’s, and Firehouse Subs, and its success is primarily driven by the success of these brands. With Patrick Doyle as Executive Chairman, QSR has triumphed over challenges and managed to see a notable increase in revenue. Appointing Doyle to the position last year was a strategic move, leveraging his success in his former role at Domino’s Pizza (DPZ). JP Morgan (JPM) anticipates improved financial performance due to QSR’s focus on “unit economics” and substantial restaurant growth worldwide, setting bullish projections for the stock. I’m sure they have embraced the challenge, and that confidence helps make QSR an attractive choice for income investors. 

QSR is currently up year-to-date by 6.71% and is trading around the middle of its existing 52-week range, with a 0.60 beta score, positive TTM (trailing twelve-month) asset and momentum growth, and a 40.21% ROE (return on equity). For its Q2 2023 earnings report, QSR posted an EPS of $1.14 per share vs. $0.77 per share as expected by analysts (a 47.84% win), also beating analysts on revenue by 1.55%. QSR also 

reported year-over-year growth in revenue (+8.3%) and net income (+2.12%). For the current fiscal quarter, QSR is expected to show $1.8 billion in sales at $0.84 per share, with a 3-5 year EPS growth rate of 5.4%. At a payout ratio of 66.67%, QSR has a 3.19% annual dividend yield and a quarterly payout of 55 cents ($2.20/year) per share. With a 10-day average volume of 1.65 million shares, QSR has a median price target of $82, with a high of $90 and a low of $70; this suggests a potential price upside of over 30%

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”QSR” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Realty Income Corp (O) 

Realty Income Corp. (O) stands out as a premier dividend stock, boasting a record of consistent dividend payouts over five decades. O’s diversified real estate portfolio, comprising both retail and commercial properties, ensures a reliable rental income stream, even during economic downturns. With a strong Q2 2023 occupancy rate of 99% and lease renewals at higher rates, O continues to exhibit resilience. As a REIT (Real Estate Investment Trust), O’s focus on its specialization in otherwise resistant market areas contributes to its stability, earning it the distinction of being one of just a few real estate trusts classified as “dividend aristocrats” with an A- or higher credit rating. Notably, O’s extensive portfolio comprises over 13,100 real estate properties, predominantly leased through long-term agreements. Recent

strategic investments, including acquiring a significant stake in the Bellagio casino and injecting $650 million in preferred equity, position O stock to profit from the resurgent market in Las Vegas. 

O is currently down by 15.17% year-to-date and is trading at the very bottom of its existing high-low range, which gives the stock room to appreciate in price. With a 0.79 beta score, O has a free cash flow of $1.54 billion and over 20% in TTM asset growth. For Q2’s earnings call, O reported revenue of $995.29 million vs. $914.91 million as expected by analysts, beating their estimates by an 8.79% margin; during this same 

period, it posted year-over-year growth in revenue (+26.85%) and operating income (+34.99%). For the present quarter, O is projected to report $970 million in sales at $0.33 per share. O has an annual dividend yield of 5.71%, a quarterly payout of 77 cents ($3.08/year) per share, and an astonishing 224.70% payout ratio. With a 10-day average volume of 6.07 million shares, O has a median price target of $68, with a high of $74 and a low of $59; this represents a possible price jump of 37.5% from its current position. 

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”O” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Duke Energy Corp (DUK) 

Last but not least is Duke Energy (DUK), which demonstrates resilience in the utilities sector, benefiting from stable demand and regulatory protections. DUK leverages geographic and economic advantages for its extensive customer base. As a public utility, it enjoys a natural monopoly that only enhances investment appeal. Despite a slight Q2 EPS miss, DUK reported revenue of $6.58 billion, surpassing expectations by around $50 million, or 8.53%, and maintained its 2023 EPS forecast, projecting a steady 5% to 7% growth rate in the years ahead. Offering a compelling dividend yield and embracing forward-looking initiatives such as an EV charging subscription service in North Carolina, DUK positions itself well for future profits. 

Currently down year-to-date by 8.35%, DUK has been trading around the middle of its existing range, and with it comes a positive ROE, positive TTM asset growth, and a very attractive beta score of 0.48. As it recently showed year-over-year revenue growth during Q2, DUK is expected to report $8.1 billion in sales at $1.97 per share for Q3’s earnings call. With an operating free cash flow of $5.68 billion, DUK has a good amount of room in the books to offer income to its shareholders. DUK has a 4.34% annual dividend yield, a quarterly payout of $1.02 ($4.08/year) per share, and a generous 80.78% payout ratio. With a 10-day average trading volume of 4.43 million shares, DUK has a median price target of $97.50, with a high of $109 and a low of $91; this implies a potential price increase of almost 16% from today’s trading price. I’d understand if you need to read that bit about DUK’s dividend a second time. 

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”DUK” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Biotech Breakthroughs: Three Standout Stocks for Growth-Minded Investors

0

While biotech stocks saw a dip earlier this year due to market uncertainties, the sector is again gaining popularity as investors seek growth opportunities. With renewed optimism in the market, there is no better time to explore the potential of investing in biotech.

Despite being a relatively new industry, biotech has rapidly evolved into one of healthcare’s most innovative and important sectors. Stocks from the group have been known to produce 5x, 10x, or even 20x gains in a very short period. No doubt about it: it’s an exciting time to invest in biotech, and today we’re featuring three standouts offering a compelling narrative for investors. Although the sector can be volatile, careful analysis of the biotech industry can help investors find promising opportunities. So, let’s look at some of the most exciting and profitable biotech stocks to buy now.

CRISPR Therapeutics (CRSP)

CRISPR Therapeutics is a leading gene editing company on the brink of commercializing the first-ever CRISPR gene therapy this year. The treatment will act as a functional cure for sickle cell disease and beta-thalassemia, with a high probability of success. As such, the risk/reward scenario for the stock is attractive, considering the potential for a transformational year ahead.

On April 3, the company announced that it had completed the rolling biologics license applications (BLAs) to the Food and Drug Administration (FDA). The BLAs seek to gain approval for the investigational treatment of exagamglogene autotemcel to treat sickle cell disease and transfusion-dependent beta-thalassemia.

CRSP is up 2% year to date and has an average price target of $75 among the 31 analysts with coverage of the stock. That implies an upside of about 80%.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”CRSP” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

TEVA Plarmeceutical Industries LTD (TEVA)

The global leader in generic drugs, Teva Pharmaceutical, is currently trading at an undeniably low 3x forward price-to-earnings multiple. One reason the stock is so cheaply priced right now is its high debt load of $20.7 billion as of the end of March. But that’s down from $21.2 billion as of the end of last year. And with the company projecting up to $2.1 billion in free cash flow for 2023, it could have room to pay down more debt this year.

Teva recently announced an agreement with Johnson & Johnson that will allow it to launch its Stelara biosimilar, AVT04, in the U.S. market by February 21, 2025, generating just under $10 billion in revenue for the healthcare giant last year. Stelara is a massive moneymaker for J&J and will provide consumers with a lower-priced alternative that could help accelerate Teva’s growth. The eight analysts offering 12-month price forecasts for Teva Pharmaceutical have a median target of $10.50, representing a 16% increase from the last price.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”TEVA” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Axsome Therapeutics (AXSM)

Axsome Therapeutics has two approved drugs on the market. Sunosi, a dopamine-norepinephrine reuptake inhibitor and the only one of its kind to treat narcolepsy, and Auvelity, a fast-acting oral treatment for depression, also the first of its kind. The latter launched in October and is being evaluated to treat agitation in people with Alzheimer’s disease and to help people quit smoking.

Other potential tailwinds include Axsome’s two other drugs — AXS-07 for treating migraines and AXS-14 for fibromyalgia — that it plans to submit for FDA approval this year. The share price is down 3% so far this year. The 14 analysts offering 12-month price forecasts for Axsome Therapeutics Inc have a median target of $108, representing a 62% increase from the current price.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”AXSM” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

How Much Further Can These Profitable AI Stocks Companies Climb? 

In 2023, tech stocks are on fire, with the S&P 500 IT (information technology) index up by 33% year-to-date. Obviously, AI stocks are leading the charge, driving the urgency to invest in big tech. 

It’s vital to remember that these stocks won’t climb endlessly. Based on the overall sentiment from Wall Street experts, we should expect corrections and a probable second rally. Some of the top AI stocks have been slowing down, leaving an opportunity for investors to hop on board. 

AI’s global economic impact is projected to be worth approximately $15.7 trillion by 2030. I, for one, think that sounds like a profitable proposition, and I suspect it sounds to you, too. 

Given how fast the tech industry has grown, these big AI players are set to deliver huge returns in the next five years, while technology only continues to advance in the meantime… 

NVIDIA Corp (NVDA) 

Nvidia (NVDA) stands out as a prime AI stock choice as it comes to mind right away. With shares recently stabilizing a little under the stock’s high of $502, there’s an opportunity for gradual accumulation and potential averaging down. NVDA’s vast addressable market, estimated by executives to be worth $600 billion, positions it for substantial growth in the expanding AI sector. NVDA is making strategic moves into markets like India, partnering with Reliance Industries and Tata Group to tap into AI’s burgeoning potential on a global scale. Already surging more than sixfold since early 2020, NVDA’s GPUs remain in high demand for generative AI applications (which aren’t going away), making it a compelling AI stock. 

NVDA is currently up year-to-date by 194.72%, has a PEG (price/earnings to growth) ratio of 1.55x, a positive 20/200 day SMA (simple moving average), and a TTM (trailing twelve-month) momentum growth measure of 242.33%. For Q2, NVDA reported EPS and revenue that exceeded analysts’ estimates by 30.31% and 21.78%, respectively; it also posted year-over-year revenue growth (+101.48%), net income (+849.23%), EPS (+853.85%), and net profit margin (+367.93%). With a low D/E (debt to equity) measure of 35.29%, NVDA carries a free cash flow of nearly $10 billion. NVDA has a modest 0.04% annual dividend yield and a quarterly payout of 4 cents ($0.16/year) per share. With a 10-day average trading volume of 43.14 million shares, NVDA has a median price target of $625, with a high of $1,100 and a low of $525; this range represents the potential for a price increase of over 155% from its current position. 

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”NVDA” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Alphabet Inc (GOOGL) 

Alphabet (GOOGL), the parent company of Google, has the potential to one day be seen as the most significant contributor to the AI revolution. Like Tesla, GOOGL’s potential role in the “robotaxi” market is substantial, particularly with its Waymo unit actively operating autonomous ride-hailing services and expanding to more locations. Moreover, like NVDA, Google is advancing in AI chip development, showcasing its cutting-edge tensor processing unit (TPU) chip that boasts superior speed and energy efficiency compared to Nvidia’s A100 GPU. GOOGL’s Cloud is excelling in the realm of generative AI integrated with different platforms, outpacing competitors like Azure and AWS in sales growth. The highly anticipated upcoming release of Gemini, a powerful generative AI tool, could position GOOGL as a strong contender against Microsoft (MSFT) and OpenAI, further accentuating its potential in the AI domain.

GOOGL is up year-to-date by 49.95%, has a positive 20/200 day SMA, a positive TTM momentum growth measure of 33.88%, a PEG ratio of 1.24x, and a very low D/E measure of 5.25%. For its Q2 2023 earnings call, GOOGL beat analysts’ on EPS by 7.29% and revenue by 2.54%, or approximately $2 billion; during this same period, it also reported year-over-year revenue growth (+7.06%), net income (+14.79%), EPS (+19.01%), net profit margin (+7.23%), and operating income (+12.27%). Scheduled to report Q3 earnings on October 24th, GOOGL is expected to post $74.7 billion in sales at $1.36 per share, with a 3-5 year EPS growth rate of 21.8%. With a 10-day average volume of 26.23 million shares, GOOGL has a median price target of $150, with a high of $200 and a low of $121; this implies over 51% price upside potential

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”GOOGL” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Meta Platforms Inc (META) 

Meta Platforms (META) presents a strong case as an AI stock to consider. They’ve successfully implemented AI to boost user engagement on Facebook. META AI-driven content recommendations lead to a 7% increase in user time spent on the platform, enhancing monetization through Reels. Notably, almost all advertisers are leveraging AI-powered tools, which include audio creation, ad performance prediction, and improved targeting. META CEO Mark Zuckerberg hints at forthcoming groundbreaking AI products. With AI adoption in digital marketing poised to grow by nearly 27% annually through 2030, META is well-positioned to expand its digital ad market share. Analysts anticipate annual earnings growth of 30%, with META’s stock price reaching around $1,100 in five yearsUp year-to-date by 152.64%, META’s stock has a PEG ratio of 0.75x, a low D/E figure of 14.78%, a positive 20/200 day SMA, and a whopping 121.53% in TTM momentum growth. META carries a free cash flow of $20.25 billion and a positive ROE of 17.35%. For its Q2 earnings, META reported EPS and revenue that surpassed analysts’ projections by 3.20% and 3.12%, respectively; at the same time, it showed critical year-over-year growth in revenue (+11.02%), net income (+16.46%), EPS (+21.14%), net profit margin (+4.91%), and operating income (+21.70%). For Q3, META is expected to report $31.2 billion in sales at $3.04 per share, with a 3-5 year EPS growth rate of 6.2%; we’ll see that come November 1st. With a 10-day average volume of 21.85 million shares, META has a median price target of $380, with a high of $435 and a low of $100; this suggests the potential for a price increase of more than 43% over its current price.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”META” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Stock Hotlist: Top Picks to Watch Now

Picking the wrong stocks can decimate your portfolio.

They’re pure portfolio poison.  

But the right stocks…

If you pick the right stocks, you could find yourself jumping for joy on top of an enormous pile of cash.

With over 4,000 tickers to choose from, finding the right stock at the right time can prove to be nearly impossible… 

Unless you’re spending hours each day combing the markets and researching companies.  

That’s why we’ve done the legwork for you.  

We sort through thousands of stock ideas and whittle them down to a few top choices that are primed for solid price action in the coming days, weeks and months.  

This week, we’ve narrowed it down to three stocks that could be getting significant attention in the near future.

Click here for the full story on the stocks we’re watching this week… 

Palo Alto Networks (PANW)

Palo Alto Networks is an unsurprising entry in the list of trending stocks, as it’s a multinational cybersecurity company. With a focus on advanced firewalls and cloud-based services that extend security coverage, PANW has gained over 64% in equity value since the beginning of the year.

According to Cybersecurity Ventures, global cybercrimes might result in a staggering $10.5 trillion cost by 2025. Furthermore, the average data breach cost in 2022 was $4.35 million, reflecting a 2.6% increase from the previous year. Given our interconnected society’s wide range of vulnerabilities, Palo Alto’s relevance remains consistent.

As one of the top-rated strong buy stocks, analysts’ average price target is $275, indicating a potential upside of more than 19%.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”PANW” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Entravision (EVC)

Entravision holds ownership of television and radio stations, as well as outdoor media, across prominent Hispanic markets. It is the largest affiliate group for Univision and UniMas TV networks while managing a few English-language TV and radio stations.

Currently, EVC boasts a market capitalization of $319.4 million and a per-share value of $3.63. However, before considering it, it’s essential to recognize that Entravision stock also carries significant risk. With a nearly 22% decline since the year’s start and a more than 19% drop in the past year, EVC’s performance has been challenging.

Despite the volatility, Entravision might pique interest due to its connection to the growing diversity in the U.S. Additionally, it’s showcasing rapid expansion, evidenced by a three-year revenue growth rate of 50.2% and an EBITDA growth rate of 51.7% within the same timeframe. Notably, analysts rate EVC as a moderate buy, offering a $11.50 price target that suggests a substantial 210% upside potential.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”EVC” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

CONSOL Energy (CEIX)

The energy sector stands out as one of the most undervalued areas in the market. Consequently, CONSOL Energy is currently trading at an exceptionally low valuation, positioning it as a prime candidate among value stocks to consider.

ESG factors have significantly influenced how investors distribute their capital, particularly as the energy landscape evolves. While renewable energy sources like solar and wind receive increased attention and investment, fossil fuels, particularly coal, have faced capital scarcity.

However, the underlying fundamentals of thermal coal remain robust. Despite the shift to cleaner energy sources in developed economies, emerging markets continue to rely on coal for energy. As per the International Energy Agency, global coal demand will remain at record levels in 2023, driven by increased demand from Asian economies. Even in 2022, coal consumption saw a 3.3% rise, indicating continued strong demand.

Benefiting from this demand, CONSOL is poised for growth. In the second quarter, the company sold 6.4 million tons, generating $521 million in revenue compared to 6.2 million tons and $518 million in the previous year.

Management disclosed that coal production for 2023 is nearly fully contracted. Additionally, they have secured contracts for 17.6 million tons in 2024 and an additional 4.4 million tons through 2026. The company boasts significant free cash flow, reporting $180.8 million in the second quarter alone. During the second-quarter earnings call, management announced plans to allocate 75% of free cash flow primarily through buyback initiatives. Given its currently depressed valuation, CONSOL has the potential to repurchase its entire market capitalization within three years.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”CEIX” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Tap Into Warren Buffett’s Riches With These Stocks 

0

Warren Buffett’s success over the years is no accident. It’s been proven (with his lucrative Berkshire Hathaway portfolio) that he has a good eye for the market and that he’s a natural investor whose wisdom and experience are both invaluable—especially in economically uncertain times. 

Unlike some YouTube finance gurus, Buffett has weathered bear markets, bull markets, inflation, stagflation… the whole lot. When he’s kind enough to share his insights, it’s prudent to pay attention. 

Within Buffett’s portfolio lies many options, and you obviously can’t invest in all of them. 

I’ve found a few Warren Buffett-owned stocks in particular that I think are appropriate for today’s list for various reasons, and rest assured that the analysts are on board… 

Louisiana-Pacific Corp (LPX) 

Based in Nashville, TN, Louisiana-Pacific (LPX) is a building materials manufacturer specializing particularly in engineered wood building products. If you heed Mr. Buffett’s advice to not bet against America, if you will, then LPX could be considered one of his more promising stock picks. Since the beginning of the year, LPX has only shown a slight return to date but is trading near the bottom of its existing range, leaving plenty of room for its price to appreciate. LPX’s handsome dividend related to its pricing is also appealing from an income-investing standpoint. 

LPX is up slightly by 0.84% year-to-date, carries a PEG (price/earnings to growth) ratio of 0.5x, has a positive ROE (return on equity), positive TTM (trailing twelve-month) momentum growth of 13.55%, and it has a nice low D/E (debt to equity) measure of 26.57%. LPX, for the current fiscal quarter, is projected to report $758 million in sales at $1.26 per share, with a 3-5 year EPS growth rate of 46.8%. LPX shows a TTM operating free cash flow of $206 million and a 1.57x P/S (price to sales) ratio. LPX has a 1.81% annual dividend yield and a quarterly payout of 24 cents ($0.96/year) per share. With a 10-day average volume of roughly 886 thousand shares, LPX has a median price target of $77, with a high of $88 and a low of $60; this suggests that there is potential for a 47.5% price leap from its current trading position. 

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”LPX” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Coca-Cola Co (KO) 

Coca-Cola Co. (KO), the iconic soft drink giant, embodies American capitalism and aligns with Warren Buffett’s investment principles. Despite a challenging 2023 so far, the good news is still there for KO in that the stock is trading around the middle of its existing range and has plenty of room for its price to climb. Volatility for the stock is considered low-risk in contrast to the broader market. Furthermore, it’s worth mentioning that analysts currently give KO a consensus strong buy rating. I’ll spotlight it below. 

Adding to the above comment regarding volatility, you can see it clearly in KO’s low 0.55 beta score. While it’s down year-to-date by 7.44%, KO has an ROE of over 40%, a positive TTM asset growth measure, and $9.31 billion in free cash flow. For Q2 2023, KO exceeded analysts’ expectations on EPS and revenue by margins of 8.14% and 1.83%, respectively; during the same time, the beverage-maker unveiled crucial year-over-year growth in revenue (+5.71%), net income (+33.70%), EPS (+34.09%) and net profit margin (+26.46%). KO has an annual dividend yield of 3.13%, a quarterly payout of 46 cents ($1.84/year) per

share, and a 74.69% payout ratio. With a 10-day average volume of 11.58 million shares, KO has a median price target of $70, with a high of $76 and a low of $63, representing a potential 30% upside

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”KO” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Nu Holdings Ltd (NU) 

Nu Holdings (NU), a financial technology (fintech) expert headquartered in Sao Paulo, Brazil, stands out as one of the potentially more volatile choices among the top Warren Buffett stocks to consider. As indicated in its public profile, NU has established itself as one of the globe’s leading independent digital banks. It has also been evident that Wall Street has a strong appetite for NU, as its shares have surged since the start of the year. Also, NU is in remarkable shape compared to where it was this time last year. 

NU is currently up by 81.33% year-to-date, has a 0.82x PEG ratio, a positive 20/200 day SMA (simple moving average), an operating free cash flow of just over $2 billion, and shows positive TTM growth in assets (+33.43%) and momentum (+34.58%). At its Q2 2023 earnings call, NU reported EPS and revenue that beat analysts’ estimates by 42.20% and 5.26%, respectively; the firm also reported year-over-year growth in critical areas like revenue (+100.40%), net income (+857.20%), EPS (+600%), and net profit margin (+477.56%). With a 10-day average trading volume of 35.04 million shares, NU has a median price target of $8.85, with a high of $11 and a low of $4; this indicates the potential for an almost 50% price upside.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”NU” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Protect Your Portfolio: These Speculative Stocks Should Be Avoided or Sold Now

0

Right now, we’re not experiencing what you’d call a broad market sell-off, but the market’s future remains uncertain, as we can agree that it’s certainly been a wild year on Wall Street. There are concerns: 

❖ High, seemingly increasing inflation 

❖ Overseas conflicts 

❖ Increased cost of living 

❖ A potential 2024 recession 

If there was ever a good time to trim some unnecessary fat from your portfolio, this may as well be it. 

Despite the unpredictability, we should be prepared for a turbulent near-term stock market, and lowering exposure to debt-ridden, volatile stocks is a prudent step… 

Lucid Group Inc (LCID) 

Perhaps a little more deceptive than the others on this list, or at least misguided, is Lucid Group Inc. (LCID), which has a market capitalization and public attention akin to Rivian Automotive (RIVN). However, rather than becoming a formidable Tesla (TSLA) competitor, RIVN looks like it’s headed for an unfortunate downfall. Investors are well aware of LCID’s letdown, hence the decline of its trading price, no longer being seen as a “Tesla killer” and dangerously close to penny stock status. While some argue for LCID’s potential in tech licensing, given the sales declines, significant cash burn, and ongoing price depreciation, it’s probably wise to steer clear. I’ll highlight a few of LCID’s downsides. 

LCID is down year-to-date by 22.04% and has a 1.69 beta score (anything over 1 indicates vulnerability). With an ROE (return on equity) of –78.61%, LCID has a disproportionately high P/S (price to sales) ratio of 12.59x. For Q2 2023’s earnings call, LCID reported an EPS of –$0.42 per share vs. –$0.33 per share as expected by analysts, a –28.55% defeat, and it lost to analysts’ revenue estimates by a –26.41% margin. During the same period, LCID showed negative year-over-year growth in net income (-246.71%), EPS (-21.21%), and net profit margin (-123.68%). With a 10-day average trading volume of 25.3 million shares, LCID has a median price target of $7.25, with a high of $10 and a low of $5

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”LCID” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

AMC Entertainment Holdings (AMC) 

AMC Entertainment (AMC) has lost its once-renowned “meme king” status, experiencing a significant share decline since August. Despite hopes for stabilization, the ongoing trend suggests that further sharp price drops for AMC could be on the horizon. The recent sell-off is primarily attributed to AMC’s substantial shareholder dilution strategy. Unfortunately for AMC, CEO Adam Aron’s attempts to present this as a positive move have not convinced investors. With the persistent issue of cash burn at AMC, which I’ll highlight next, the probability of more problems remains high, making this stock one to avoid. 

AMC is currently down year-to-date by 77.95%, trading at the very bottom of its existing 52-week range. With a 2.02 beta score, AMC has a stunningly backward ROE of –1,913.03%, a negative free cash flow of –$460 million, and perhaps most surprising, a total of $9.5 billion in debt, which is more than $8 billion

higher than its market capitalization. AMC shows negative quarterly EPS growth (-202.35%) and revenue growth (-20.85%). With a 10-day average trading volume of 26.09 million shares, AMC has a median price target of $7.38, with a high of $45 and a low of $4.41; this suggests a 7% decrease from its current price

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”AMC” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Hudson Pacific Properties Inc (HPP) 

Particularly among REITs (real estate investment trusts), Hudson Pacific Properties (HPP) has found itself in a precarious position. The ongoing work-from-home trend continues to impact HPP’s office portfolio, and Hollywood union strikes present major financial challenges for its sound stages and film and TV production facilities. Despite a temporary climb in shares, HPP’s stock is once again declining, triggered by the decision to halt dividend payments. Even if the Hollywood strikes were to end soon, other concerns, such as HPP’s growing debt and increasing interest expenses, pose substantial risks. Considering these factors and that it no longer offers a dividend, HPP is a stock that should be dumped. 

HPP is down year-to-date by 30.65%, has a 1.16 beta score, a negative ROE, a TTM (trailing twelve-month) momentum growth figure of –33.60%, and a D/E (debt to equity) measure of 141.12%. HPP currently holds shy of $5 billion in debt, more than five times higher than its $950 million market capitalization. For Q2 2023, HPP reported negative year-over-year growth in revenue (-3.46%), net income (-1,483.99%), EPS (-420%), net profit margin (-1,550%), and operating income (-55.32%). Scheduled to report Q3 earnings on November 2nd, HPP is projected to post $239 million in sales at –$0.20 per share. With a 10-day average volume of 4.75 million shares, HPP has a median price target of $6.50, with a high of $11 and a low of $4; this implies a price drop of almost 4% from where it currently trades. 

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”HPP” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

A Closer Look: What You Should Know About Ford (F) and the UAW Strike 

0

Renowned automaker Ford Motor Co. (F) recently decided to stop its $3.5 billion project to construct an EV battery plant in Marshall, MI. This decision wasn’t a simple one to make and was influenced by financial challenges caused by the autoworker strikes and mounting political pressure from lawmakers. 

Earlier this year, Ford unveiled ambitious plans for the plant, aiming to employ 2,500 workers dedicated to producing EV batteries. F‘s choice to collaborate with the Chinese giant, Contemporary Amperex Technology Co. (CATL), the world’s largest battery manufacturer, was a significant factor in its plans. 

However, there have since been allegations of CATL being involved with forced labor, which saw Ford (F) catch heat from Congress. The U.S. government had already passed legislation that deemed imports from China subject to verification that they were, or are, NOT associated with forced labor

With this not only being a socio-political issue but a financial burden, it’s natural for investors to wonder how this will affect Ford’s stock in the near future. Let’s explore this together… 

While CATL claims to have rid itself of all its holdings in Xinjiang, a region of China where forced labor is known to be a widespread problem, committee investigators maintain that the company still has ties to mining activities in the area. Ford Motors (F) has clarified that it isn’t procuring materials from CATL but is solely utilizing its technology. Additionally, the U.S.-based automaker has expressed its intention to collaborate with CATL to address human rights issues through its supply chain. 

T.R. Reid, a spokesperson for Ford (F), conveyed the company’s stance, stating, “We are pausing work and limiting spending on construction on the Marshall project until we’re confident that we’ll be able to competitively operate the plant.” He also emphasized, though, that a final decision has not yet been made. 

In response, Rep. Mike Gallagher, chair of the Select Committee on the Chinese Communist Party, welcomed F‘s decision to reevaluate its partnership with CATL and suggested that it should reconsider the entire Marshall plant project due to CATL‘s alleged ties to forced labor. 

The situation has also been on the Senate Finance Committee’s radar. It’s had no problem scrutinizing Ford and other Western automakers for their relationships with Chinese firms (in the context of forced labor in the auto industry). 

However, some lawmakers caution against prematurely passing judgment or reacting unreasonably, arguing that it could jeopardize a facility that is pivotal in helping the U.S. compete with China in EV production and bringing much-needed manufacturing jobs to the state of Michigan. These developments come at a time when UAW (United Auto Workers) members are on strike at a Ford plant in Michigan. 

President Joe Biden has expressed significant support for the UAW members and the strike’s cause, going so far as to show up at the plant and actually join the workers on the picket lines. This is something that, at least as far as records can tell, has not been done before by a sitting U.S. President. 

F had previously underscored the importance of collaborating with CATL with its ambitious global expansion plans for electric vehicle production. However, this relationship is now under a microscope, being watched closely by congressional investigators as policymakers debate which vehicles —

particularly those incorporating Chinese technology — should be eligible for the tax incentives provided by the Inflation Reduction Act, aimed at promoting EV production in the U.S. 

This whole situation certainly presents an interesting dynamic for investors to monitor closely, given the potential implications for F‘s future endeavors in the EV market—how ambitious will they be? For now, let’s at least take a look at how the stock has been performing: 

F is currently up year-to-date by 6.96%, yet comes with reasonable pricing as it trades between the bottom and middle of its existing 52-week range. With a positive ROE (return on equity), momentum growth, and asset growth on a TTM (trailing twelve-month) basis, F carries an operating free cash flow of $12.82 billion. F has a PEG (price/earnings to growth) ratio of 0.65x, a forward P/E (price to earnings) ratio of 6.33x, a P/S (price to sales) ratio of 0.3x, and a P/B (price to book) ratio of 1.15x. F has a 4.83% annual dividend yield, with a quarterly payout of 15 cents ($0.60/year) per share and a 58.35% payout ratio

For its Q2 2023 earnings call, F reported an EPS of $0.72 per share vs. $0.54 per share, beating analysts’ estimates by 34.28%, and revenue of $42.43 billion, which was over $1 billion more than what the analysts projected (a 2.68% win). F also reported year-over-year growth in revenue (+11.85%), net income (+187.41%), EPS (+193.75%), and net profit margin (+156.63%). For Q3, F is expected to post $44 billion in sales at $0.36 per share, with a 3-5 year EPS growth rate of 15%; the firm is scheduled for October 25th. With a 10-day average volume of 48.35 million shares, F has a median price target of $14.80, with a high of $23 and a low of $11, representing the potential for an upside potential of nearly 85%

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”F” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Popular Posts

My Favorites

Mark Your Calendar: This Biotech Stock Could Surge Next Week

0
A single positive or negative announcement from the US Food and Drug Administration (FDA) can send shares of a biotech firm soaring.   On February 28th,...